4.8 Article

Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2

Journal

MOLECULAR CELL
Volume 6, Issue 3, Pages 693-704

Publisher

CELL PRESS
DOI: 10.1016/S1097-2765(00)00067-8

Keywords

-

Funding

  1. NCI NIH HHS [P0I CA 66996] Funding Source: Medline
  2. NIDDK NIH HHS [P0I DK 50654] Funding Source: Medline
  3. NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050654] Funding Source: NIH RePORTER

Ask authors/readers for more resources

STATE is activated in a broad spectrum of human hematologic malignancies. We addressed whether STATE activation is necessary for the myelo- and lymphoproliferative disease induced by TEL/JAK2 using a genetic approach. Whereas mice transplanted with bone marrow transduced with retrovirus expressing TEL/JAK2 develop a rapidly fatal myelo- and lymphoproliferative syndrome, reconstitution with bone marrow derived from Stat5ab-deficient mice expressing TEL/JAK2 did not induce disease. Disease induction in the Stat5a/b-deficient background was rescued with a bicistronic retrovirus encoding TEL/JAK2 and Stat5a. Furthermore, myeloproliferative disease was induced by reconstitution with bone marrow cells expressing a constitutively active mutant, Stat5a, or a single Stat5a target, murine oncostatin M (mOSM). These data define a critical role for Stat5a/b and mOSM in the pathogenesis of TEL/JAK2 disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available